⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30092672 | 0.98 | — | — | |
| SCHEMBL7377426 | 0.98 | — | — | |
| Fumaric Acid SCHEMBL35210763 | 0.88 | TSHR (0.33) | — | |
| Trifluoroacetic Acid SCHEMBL28859339 | 0.87 | HRH4 (0.39) | — | |
| SCHEMBL30587567 | 0.85 | — | — | |
| SCHEMBL28947307 | 0.81 | CCNC (0.30) | — | |
| SCHEMBL9663668 | 0.80 | P2RX7 (0.30) | — | |
| SCHEMBL19281540 | 0.79 | GDA (0.31) | — | |
| SCHEMBL29486 | 0.78 | — | — | |
| Adenine SCHEMBL19057035 | 0.76 | PI4KA (0.61) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1371 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731224-A1 | DOSAGE REGIMENS FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES USING LY3871801 | Eli Lilly and Company (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4055021-B1 | HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS | RIGEL PHARMACEUTICALS INC (US) | 2025-10-08 | — | — | EP | claimed |
| EP-4025568-B1 | RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME | RIGEL PHARMACEUTICALS INC (US) | 2025-05-14 | — | — | EP | claimed |
| EP-4547335-A2 | ANTI-SARS-COV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF | Modex Therapeutics, Inc. (US) | 2025-05-07 | — | — | EP | claimed |
| EP-4025574-B1 | RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME | RIGEL PHARMACEUTICALS INC (US) | 2025-05-07 | — | — | EP | claimed |
| EP-4547711-A2 | ANTI-SARS-COV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF | Modex Therapeutics, Inc. (US) | 2025-05-07 | — | — | EP | claimed |
| EP-3526209-B1 | HETEROCYCLIC APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF | RES TRIANGLE INST (US) | 2025-04-16 | — | — | EP | claimed |
| CN-119836434-A | Anti-SARS-CoV-2 antigen binding polypeptides, polypeptide complexes, and methods of use thereof | 摩德斯医疗股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119654311-A | Carbobicyclic nucleosides for treatment of viral infections | 香港中文大学 | 2025-03-18 | — | — | CN | claimed |
| CN-119528914-A | Benzazepine ketone derivative and application thereof | 杭州百诚医药科技股份有限公司 | 2025-02-28 | — | — | CN | claimed |
| EP-0220956-A2 | Herbicidal 1,2,4-triazole-3-carboxamides | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1987-05-06 | — | — | EP | claimed |
| US-4614719-A | REACTION OF 1,2,4-TRIAZOLE-CARBOXAMIDE AND RIBOSE DONOR IN PRESENCE OF BREVEBACTERIUM CATALYST | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1986-09-30 | — | — | US | claimed |
| US-4578479-A | Process for preparing 1,2,4-triazole-3-carboxamides | UBE INDUSTRIES, LTD. (JP) | 1986-03-25 | — | — | US | claimed |
| US-4492597-A | 1,5-Diphenyl derivative of 1,2,4-triazole-3-carboxamide and herbicide containing the same | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1985-01-08 | — | — | US | claimed |
| EP-0070089-B1 | 1,2,4-TRIAZOLE DERIVATIVES HAVING HERBICIDAL ACTIVITY | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1984-12-05 | — | — | EP | claimed |
| EP-0126326-A1 | Process for preparing 1,2,4-triazole-3-carboxamides | UBE INDUSTRIES, LTD. (JP) | 1984-11-28 | — | — | EP | claimed |
| EP-0027189-B1 | 2.5-DIKETOPIPERAZINE-DERIVATIVE, PROCESS FOR ITS PREPARATION AND ITS USE | BAYER AG (DE) | 1984-02-22 | — | — | EP | claimed |
| EP-0093401-A1 | Process for producing ribavirin | Yamasa Shoyu Kabushiki Kaisha (JP) | 1983-11-09 | — | — | EP | claimed |
| EP-0070089-A1 | 1,2,4-Triazole derivatives having herbicidal activity | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1983-01-19 | — | — | EP | claimed |
| US-3976545-A | WITH NUCLEOSIDE PHOSPHORYLASE AND RIBOSE-1-PHOSPHATE TO FORM 1-B-D-RIBOFURANOSYL | ICN PHARMACEUTICALS, INC. (US) | 1976-08-24 | — | — | US | claimed |